Manufacturer of Controlled Substances Notice of Application, 28052 [E6-7338]
Download as PDF
<![CDATA[
28052
Federal Register / Vol. 71, No. 93 / Monday, May 15, 2006 / Notices
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application For Restoration of Firearms
Privileges.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: ATF F 3210.1,
Bureau of Alcohol, Tobacco, Firearms
and Explosives.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals or
households. Other: Business or other for
profit. Certain categories of persons are
prohibited from possessing firearms.
ATF F 3210.1, Application For
Restoration of Firearms Privileges is the
basis for ATF investigating the merits of
an applicant to have his/her rights
restored.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 250
respondents will complete a 30 minute
form.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 125
annual total burden hours associated
with this collection.
FOR FURTHER INFORMATION CONTACT:
jlentini on PROD1PC65 with NOTICES
Robert B. Briggs, Department Clearance
Officer, Policy and Planning Staff,
Justice Management Division,
Department of Justice, Patrick Henry
Building, Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Application
[Docket No. DEA–218N]
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on December
14, 2005, and February 14, 2006,
Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in Schedule
II:
Electronic Prescriptions for Controlled
Substances; Notice of Meeting
Drug
Schedule
Dihydrocodeine (9120) .................
Oxymorphone (9652) ...................
The company plans to manufacture in
bulk, for distribution to its customers,
who are final dosage manufacturers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 14, 2006.
Dated: May 9, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7338 Filed 5–12–06; 8:45 am]
BILLING CODE 4410–09–P
Dated: May 10, 2006.
Robert B. Briggs,
Department Clearance Officer, Department of
Labor.
[FR Doc. 06–4513 Filed 5–12–06; 8:45 am]
BILLING CODE 4410–FY–M
VerDate Aug<31>2005
16:54 May 12, 2006
Jkt 208001
II
II
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
RIN 1117–AA61
Drug Enforcement
Administration (DEA), Justice.
ACTION: Notice of meeting.
AGENCY:
SUMMARY: The Drug Enforcement
Administration (DEA), in conjunction
with the Department of Health and
Human Services (HHS), is conducting a
public meeting to discuss electronic
prescriptions for controlled substances.
Specifically, this meeting is intended to
allow industry—prescribers,
pharmacies, software/hardware vendors,
and other interested third parties—to
address how electronic prescribing
systems can meet DEA’s prescription
requirements under the Controlled
Substances Act, without unduly
burdening the parties to electronic
prescribing transactions.
DATES: This meeting will be held
Tuesday, July 11, 2006, and Wednesday,
July 12, 2006, 8:30 a.m. until 5:30 p.m.
Registration will begin at 7:30 a.m. This
meeting will be held at the Marriott
Crystal City at Reagan National Airport,
1999 Jefferson-Davis Highway,
Arlington, VA 22202; (703) 413–5500.
The meeting will take place in the
Crystal Forum amphitheatre, adjacent to
the hotel.
Meeting Attendance: To ensure proper
handling, please reference ‘‘Docket No.
DEA–218N’’ on all written and
electronic correspondence regarding
this meeting. Persons wishing to attend
this meeting, space permitting, must
provide attendee information to the
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, via e-mail to
dea.diversion.policy@usdoj.gov, or via
facsimile, (202) 353–1079, as specified
below. Persons wishing to attend the
meeting must provide this information
to the Liaison and Policy Section no
later than June 26, 2006.
Comments: All written comments will
be made available at the Diversion
Control Program Web site, https://
www.deadiversion.usdoj.gov prior to the
public meeting. Therefore, as this is a
public meeting, confidential business
information or other proprietary
information SHOULD NOT be presented
at this meeting.
Persons wishing to provide written
comments must do so no later than June
26, 2006. To ensure proper handling of
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 71, Number 93 (Monday, May 15, 2006)]
[Notices]
[Page 28052]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7338]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on December 14, 2005, and
February 14, 2006, Johnson Matthey Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Dihydrocodeine (9120)...................... II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture in bulk, for distribution to its
customers, who are final dosage manufacturers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than July 14, 2006.
Dated: May 9, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-7338 Filed 5-12-06; 8:45 am]
BILLING CODE 4410-09-P
